JW Pharmaceutical Corporation Stock: price and insider trades · South Korea
JW중외제약
No insider purchase over the last 90 days. The latest, by 이기환, was filed 07 Jan 2026.
JW Pharmaceutical Corporation: what insiders have been doing
This page follows insider dealings at JW Pharmaceutical Corporation as filed with DART (FSS), a company from the Health Care sector. From 1 November 2025 to 1 November 2026, the disclosure feed for JW Pharmaceutical Corporation logged 3 filings by 2 insiders.
Not one open-market sale was filed. On the buying side, 1 insider reported 1 purchase. The totals do not cover 1 filing with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 senior executive.
The latest purchase dates back some time: it was published 305 days ago, on 7 January 2026.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 3 filings, this issuer sits below that mark. Since 2021, the database holds 19 purchases and 2 sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 9,370 sharesShareKRXDART:20260107000322Canonical exit: 7 Apr 2026 (T+90)
- 243,687 sharesKRXDART:20250702000232
- 5,288 sharesKRXDART:20250404003610
- ●Executives0DART
- 188 sharesShareKRXDART:20250107000250Canonical exit: 7 Apr 2025 (T+90)
- 1,107 sharesShareKRXDART:20241209000183Canonical exit: 9 Mar 2025 (T+90)
- 3,817 sharesKRXDART:20241007000071Canonical exit: 18 Dec 2024 (T+90)
- 0KRXDART:20240703000445
- 11 sharesShareKRXDART:20240207000920Canonical exit: 31 Mar 2024 (T+90)
- 11 sharesShareKRXDART:20240207000914Canonical exit: 31 Mar 2024 (T+90)
- 2,787 sharesShareKRXDART:20240207000905Canonical exit: 31 Mar 2024 (T+90)
- 192,295 sharesShareKRXDART:20240207000866Canonical exit: 31 Mar 2024 (T+90)
- 195,860 sharesKRXDART:20240207000857Canonical exit: 31 Mar 2024 (T+90)
- 0KRXDART:20230630000779
- ShareKRXDART:20230410003274Canonical exit: 9 Jul 2023 (T+90)
- ShareKRXDART:20230410003254Canonical exit: 9 Jul 2023 (T+90)
- ShareKRXDART:20230410003217Canonical exit: 9 Jul 2023 (T+90)
- ShareKRXDART:20230410003235Canonical exit: 9 Jul 2023 (T+90)
- ShareKRXDART:20230410003192Canonical exit: 9 Jul 2023 (T+90)
- ShareKRXDART:20230410003162Canonical exit: 9 Jul 2023 (T+90)
- 0KRXDART:20230410003130
25 of 39 declarations
About JW Pharmaceutical Corporation
JW Pharmaceutical is a South Korean pharmaceutical company focused on the development and commercialization of medications. It is listed on the Korea Exchange, XKRX.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
